Lumicell Announces FDA Advisory Committee ’s Positive Recommendation on the Benefit-Risk Profile of Lumisight in the Detection of Cancerous Tissue During Breast Conserving Surgery

NEWTON, Massachusetts March 6, 2024– Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer, today announced the Medical Imaging Drugs Advisory Committee (MIDAC) of the U.S Food and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news